Take Action
Add your voice to the Animal Legal Defense Fund's initiatives to improve the lives and advance the interests of animals through the legal system.
The Animal Legal Defense Fund works at the federal, state and local levels to advance important legislation. We advocate for laws that promote or protect the lives and interests of animals, and we oppose legislation that would be detrimental to animals’ well-being.
National Actions
Petition: Protect Wyoming’s Wildlife from Cruelty
Petition: Ban Octopus Farming Today!
Urge Federal Legislators to Support the SWIMS Act!
Require Wildlife Services to prioritize non-lethal methods!
State Actions
Check for state-level actions you can take:
Massachusetts: Ensure that dogs and their families can stay together
Massachusetts: Ask your legislators to support Ollie’s Law
Massachusetts: Ban Cat Declawing
Massachusetts: Ask Your Legislators to Strengthen Animal Cruelty Laws
Massachusetts: Help end animal testing for cosmetics and other products
Massachusetts: Keep Animals Away from Abusers
Massachusetts: Help Protect Animals from Inhumane Circuses and Traveling Acts
Massachusetts: Ask Your State Legislators to Help Protect Animals from Rat Poisons
Sign Up!
Join the Animal Legal Defense Fund's email list to stay up to date on lawsuits, legislation, and regulations affecting animals.
Stop Ag-Gag Laws
No More Puppy Mills
Related
-
Animal Legal Defense Fund Grant Supported Washington Attorney General’s Enforcement of Animal Cruelty Law
The judge sentenced a Snohomish County resident for killing then displaying neighborhood wildlife and shooting a kitten in the eye.April 18, 2024 News -
REPORT: 95 Percent of Consumers Prefer “Climate-Friendly” Products, But Labels Oversell Emission Reductions
New report reveals how misleading labels lead to increased confusion among consumers searching for more sustainable, less environmentally damaging products.April 2, 2024 Press Release -
Lawsuit Filed Demanding FDA Respond to Petitions Seeking to Ban Ractopamine
FDA’s approval for ractopamine relied primarily on safety studies conducted by the drugmaker.March 26, 2024 Press Release